Luke Anthony Wittenburg

Title(s)Associate Professor, School of Veterinary Medicine
SchoolUniversity of California, Davis
Address218 CCAH
CA 95616
Phone530-754-5711
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Serum concentrations of gabapentin in cats with chronic kidney disease. J Feline Med Surg. 2022 Feb 23; 1098612X221077017. Quimby JM, Lorbach SK, Saffire A, Kennedy A, Wittenburg LA, Aarnes TK, Creighton KJ, Jones SE, Paschall RE, King EM, Bruner CE, Wallinger JN, van Haaften KA. PMID: 35195476.
      View in: PubMed   Mentions:
    2. Microglia-Derived Olfactomedin-like 3 Promotes Pro-Tumorigenic Microglial Function and Malignant Features of Glioma Cells. Int J Mol Sci. 2021 Dec 02; 22(23). Toedebusch RG, Lucchesi CA, Debebe ET, Wittenburg LA, Chen X, Toedebusch CM. PMID: 34884869; PMCID: PMC8657851.
      View in: PubMed   Mentions:
    3. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma. Vet Comp Oncol. 2020 Mar; 18(1):52-63. Alegre F, Ormonde AR, Godinez DR, Illendula A, Bushweller JH, Wittenburg LA. PMID: 31381810; PMCID: PMC7233265.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    4. Pilot study comparing serum chemotherapy levels after intra-arterial and intravenous administration in dogs with naturally occurring urinary tract tumors. Can J Vet Res. 2019 Jul; 83(3):187-196. Kirsch M, Weisse C, Berent A, Clifford C, Leibman N, Wittenburg L, Solomon SB, Lamb K. PMID: 31308591; PMCID: PMC6587882.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    5. Doxorubicin area under the curve is an important predictor of neutropenia in dogs with naturally occurring cancers. Vet Comp Oncol. 2019 Jun; 17(2):147-154. Wittenburg LA, Weishaar K, Ramirez D, Gustafson DL. PMID: 30638304; PMCID: PMC6478528.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    6. A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma. PLoS One. 2018; 13(12):e0209941. Alegre F, Ormonde AR, Snider KM, Woolard K, Yu AM, Wittenburg LA. PMID: 30596759; PMCID: PMC6312226.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    7. Simultaneous absolute quantitation of ATP-binding cassette transporters in normal dog tissues by signature peptide analysis using a LC/MS/MS method. Res Vet Sci. 2019 Feb; 122:93-101. Wittenburg LA, Ramirez D, Conger H, Gustafson DL. PMID: 30500618; PMCID: PMC6522139.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    8. In vivo and in vitro assessment of mirtazapine pharmacokinetics in cats with liver disease. J Vet Intern Med. 2018 Nov; 32(6):1951-1957. Fitzpatrick RL, Quimby JM, Benson KK, Ramirez D, Sieberg LG, Wittenburg LA, Gustafson DL. PMID: 30307637; PMCID: PMC6272035.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    9. In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers. Vet Comp Oncol. 2018 Dec; 16(4):571-579. Withers SS, York D, Johnson E, Al-Nadaf S, Skorupski KA, Rodriguez CO, Burton JH, Guerrero T, Sein K, Wittenburg L, Rebhun RB. PMID: 30088848; PMCID: PMC6234083.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    10. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res. 2018 Jul; 82(3):178-183. Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. PMID: 30026641; PMCID: PMC6038832.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    11. Preliminary pharmacokinetics of intravenous and subcutaneous dolasetron and pharmacodynamics of subcutaneous dolasetron in healthy cats. J Feline Med Surg. 2018 08; 20(8):721-727. Herndon AK, Quimby JM, Sieberg LG, Davis L, Caress AL, Ligas S, Hansen RJ, Wittenburg LA, Gustafson DL. PMID: 28905667.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    12. Assessment of absorption of transdermal ondansetron in normal research cats. J Feline Med Surg. 2017 Dec; 19(12):1245-1248. Zajic LB, Herndon AK, Sieberg LG, Caress AL, Morgan PK, Hansen RJ, Wittenburg LA, Gustafson DL, Quimby JM. PMID: 28112563.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    13. Anti-inflammatory drugs decrease infection of brain endothelial cells with EHV-1 in vitro. Equine Vet J. 2017 Sep; 49(5):629-636. Goehring LS, Brandes K, Ashton LV, Wittenburg LA, Olea-Popelka FJ, Lunn DP, Soboll Hussey G. PMID: 27864898.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    14. Docetaxel Accumulates in Lymphatic Circulation Following Subcutaneous Delivery Compared to Intravenous Delivery in Rats. Anticancer Res. 2016 10; 36(10):5071-5078. Worley DR, Hansen RJ, Wittenburg LA, Chubb LS, Gustafson DL. PMID: 27798866; PMCID: PMC5501171.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    15. Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study. J Feline Med Surg. 2017 Oct; 19(10):998-1006. Benson KK, Zajic LB, Morgan PK, Brown SR, Hansen RJ, Lunghofer PJ, Wittenburg LA, Gustafson DL, Quimby JM. PMID: 27613493; PMCID: PMC5647142.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCTClinical Trials
    16. Plasma, subcutaneous tissue and bone concentrations of ceftiofur sodium after regional limb perfusion in horses. Equine Vet J. 2017 May; 49(3):341-344. Cox KS, Nelson BB, Wittenburg L, Gold JR. PMID: 27458113.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCTClinical Trials
    17. The Effects of Mepivacaine Hydrochloride on Antimicrobial Activity and Mechanical Nociceptive Threshold During Amikacin Sulfate Regional Limb Perfusion in the Horse. Vet Surg. 2016 Aug; 45(6):798-803. Colbath AC, Wittenburg LA, Gold JR, McIlwraith CW, Moorman VJ. PMID: 27416788.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCTClinical Trials
    18. Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver disease. J Vet Pharmacol Ther. 2016 Aug; 39(4):350-5. Fitzpatrick RL, Wittenburg LA, Hansen RJ, Gustafson DL, Quimby JM. PMID: 26667224; PMCID: PMC6994184.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    19. Pharmacokinetics and bioavailability of orbifloxacin oral suspension in New Zealand White rabbits (Oryctolagus cuniculus). Am J Vet Res. 2015 Nov; 76(11):946-51. Watson MK, Wittenburg LA, Bui CT, Jarosz KA, Gustafson DL, Johnston MS. PMID: 26512539.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    20. Pharmacokinetics and pharmacodynamics of the factor Xa inhibitor apixaban after oral and intravenous administration to cats. Am J Vet Res. 2015 Aug; 76(8):732-8. Myers JA, Wittenburg LA, Olver CS, Martinez CM, Bright JM. PMID: 26207972.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    21. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy. 2014 Aug; 10(8):1415-25. Barnard RA, Wittenburg LA, Amaravadi RK, Gustafson DL, Thorburn A, Thamm DH. PMID: 24991836; PMCID: PMC4203518.
      View in: PubMed   Mentions: 75     Fields:    Translation:AnimalsCTClinical Trials
    22. Endometrial tissue and blood plasma concentration of ceftiofur and metabolites following intramuscular administration of ceftiofur crystalline free acid to mares. Equine Vet J. 2014 Sep; 46(5):606-10. Scofield D, Black J, Wittenburg L, Gustafson D, Ferris R, Hatzel J, Traub-Dargatz J, McCue P. PMID: 24111546.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    23. A pilot phase II study of the efficacy and biosafety of doxorubicin chemotherapy in tumor-bearing equidae. J Vet Intern Med. 2013 Nov-Dec; 27(6):1581-8. Théon AP, Pusterla N, Magdesian KG, Wittenburg L, Marmulak T, Wilson WD. PMID: 24107145.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsPHPublic HealthCTClinical Trials
    24. Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs. Vet Ophthalmol. 2014 Sep; 17(5):328-33. Arnold TS, Wittenburg LA, Powell CC. PMID: 23802568.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    25. Development of a limited-sampling model for prediction of doxorubicin exposure in dogs. Vet Comp Oncol. 2014 Jun; 12(2):114-9. Wittenburg LA, Thamm DH, Gustafson DL. PMID: 22747489; PMCID: PMC3897556.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    26. A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma. J Cell Biochem. 2012 Mar; 113(3):773-83. Wittenburg LA, Ptitsyn AA, Thamm DH. PMID: 21976144; PMCID: PMC4667946.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    27. Optimizing preclinical study design in oncology research. Chem Biol Interact. 2011 Apr 25; 190(2-3):73-8. Wittenburg LA, Gustafson DL. PMID: 21296059.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer. Clin Cancer Res. 2010 Oct 01; 16(19):4832-42. Wittenburg LA, Gustafson DL, Thamm DH. PMID: 20705615; PMCID: PMC2948605.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCTClinical Trials
    29. The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin. Cancer Chemother Pharmacol. 2011 Jan; 67(1):83-92. Wittenburg LA, Bisson L, Rose BJ, Korch C, Thamm DH. PMID: 20306194; PMCID: PMC2916050.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    Luke Anthony's Networks
    Concepts (172)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California